TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Researchers from University of Tennessee report details of new studies and findings in the area of tuberculosis
June 17th, 2008
"Ethambutol is one of the front-line agents recommended by the World Health Organization for the treatment of tuberculosis," scientists in the United States report. "In an effort to develop more potent therapies to treat tuberculosis, novel unsymmetrical ethambutol analogues were successfully synthesized by a new route utilizing novel building blocks synthesized using Ellman's sulfinyl chemistry," wrote R. Yendapally and colleagues, University of Tennessee. The researchers concluded: "The resulting analogues were tested for anti-tuberculosis activity yielding compounds with comparable anti-tuberculosis activity to ethambutol and increased...
Source: TB & Outbreaks Week (2008-06-17)
|
